Flagship Harbor Advisors, LLC Synlogic, Inc. Transaction History

Flagship Harbor Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 12, 2023	SELL	$0.56 - $1.07 $2,800 - $5,350	-5,000 Reduced 12.5%	35,000 $22,000
Q4 2022 Jan 13, 2023	SELL	$0.58 - $17.99 $9,280 - $287,840	-16,000 Reduced 28.57%	40,000 $0
Q3 2022 Oct 13, 2022	SELL	$0.91 - $14.63 $4,550 - $73,150	-5,000 Reduced 8.2%	56,000 $53,000
Q2 2022 Jul 13, 2022	SELL	$0.89 - $2.47 $7,120 - $19,760	-8,000 Reduced 11.59%	61,000 $70,000
Q2 2021 Jul 26, 2021	BUY	$3.0 - $4.39 $30,000 - $43,900	10,000 Added 16.95%	69,000 $268,000
Q1 2021 May 03, 2021	BUY	$2.2 - $5.05 $90,200 - $207,050	41,000 Added 227.78%	59,000 $211,000
Q4 2020 Feb 08, 2021	BUY	$1.85 - $2.54 $11,100 - $15,240	6,000 Added 50.0%	18,000 $39,000
Q3 2020 Oct 13, 2020	SELL	$1.85 - $2.57 $5,550 - $7,709	-3,000 Reduced 20.0%	12,000 $24,000
Q3 2019 Oct 22, 2019	BUY	$2.12 - $9.37 $31,800 - $140,550	15,000 New	15,000 $34,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.